Cellular mucins: Targets for immunotherapy

Critical Reviews in Immunology

Volumn 14, Issue 3-4, 1994, Pages 293-309

  Apostolopoulos, V ^a   McKenzie, I F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

antigen; immunotherapy; mucins; peptides; tumor; vaccine

Indexed keywords

BCG VACCINE; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR; EPITOPE; GAMMA INTERFERON; GLYCOCONJUGATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; INTERLEUKIN 6; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; MUCIN; PHOSPHORYL LIPID A; TUMOR ANTIGEN;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; BREAST ADENOCARCINOMA; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CARBOHYDRATE ANALYSIS; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOGENICITY; OVARY ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; TANDEM REPEAT; VACCINATION; VACCINIA VIRUS;

EID: 0028649555     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v14.i3-4.40     Document Type: Review

References (0)